CNMV - Inside information of the day

31/03/2025 Nueva oferta de empleo con 36 plazas para personal laboral fijo, apúntate antes del 28 de abril.

Home >
Inside information >
Inside information of the day

03/04/2025

- 13:36
- CLINICA BAVIERA, S.A. (BAVIERA)
- On significant placements in financial instruments
- Alantra announces details of an accelerated bookbuild process of up to 8% of the share capital of Clínica Baviera, S.A. (Replaces the previous one)
- - Corrects or supplements communication no. 2687 dated 03/04/2025 (07:58)
- 08:27
- PHARMA MAR, S.A.
- On business and financial situation
- Pharma Mar signs a licensing, development and commercialization agreement with Merck for lurbinectedin in Japan.
- 07:58
- CLINICA BAVIERA, S.A. (BAVIERA)
- On significant placements in financial instruments
- Alantra announces details of an accelerated bookbuild process of up to 8% of the share capital of Clínica Baviera, S.A.
- - Related to communication no. 2686 dated 02/04/2025 (17:56)
  - Corrected or supplemented by communication no. 2689 dated 03/04/2025 (13:36)

02/04/2025 (After logging off)

- 17:56
- CLINICA BAVIERA, S.A. (BAVIERA)
- On significant placements in financial instruments
- Alantra announces the beginning of an accelerated bookbuild process of up to 8% of the share capital of Clínica Baviera, S.A.

The CNMV publishes this information in accordance with the provisions of article 228 of the Spanish Securities Market Act, and it shall not be liable for the veracity of its content.